Maximus Inc. (MMS) shares plunged 5.21% in Thursday's trading session after the company reported mixed results for the fiscal first quarter ended December 31, 2024.
While the government health services provider posted adjusted earnings per share of $1.61, exceeding analyst estimates of $1.37, it missed on fourth-quarter EPS expectations, reporting $0.69 versus the consensus estimate of $1.06.
On the positive side, Maximus' revenue for the quarter came in at $1.4 billion, surpassing the $1.29 billion forecasted by analysts. Additionally, the company raised its fiscal 2025 adjusted EPS guidance to a range of $5.90 to $6.20, up from its previous outlook of $5.70 to $6.00.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。